Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
ProCell Therapeutics
Seoul, South Korea
A
1-10 Employees
2005
Key takeaway
ProCell Therapeutics, Inc. is focused on becoming a leader in the biopharmaceutical sector, which may encompass advancements in peptide therapeutics. Their expertise in drug development and innovative technologies positions them as a key player in this field.
Reference
Core business
프로셀테라퓨틱스
MITT,MTD,거대분자세포내전송기술보유,신약개발,바이오벤처기업,피투스킨,성장인자원료,기능성화장품,OEM,ODM
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion is a global biopharmaceutical company that offers comprehensive solutions throughout the biopharmaceutical process, from R&D to distribution. With a strong focus on innovation and a commitment to improving patient care, Celltrion is well-positioned in the biotechnology sector.
Reference
Product
Technology
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
BIORCHESTRA focuses on developing innovative RNA medicines and delivery systems addressing unmet medical needs in neurodegenerative and rare diseases. Their best-in-class technology enhances the targeted delivery of RNA therapeutics, which may include peptide-based approaches.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Plexense
Seongnam-si, South Korea
A
1-10 Employees
2012
Key takeaway
Plexense, Inc. has been focused on developing advanced diagnostic kits, which may involve innovative therapeutic approaches. Their collaboration with leading institutions suggests a commitment to cutting-edge research and technology.
Reference
Core business
About Us | Plexense
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is focused on advancing peptide therapeutics through multi-target drug development. Their flagship program, OGB21502, highlights their commitment to innovative treatments, particularly for complex diseases.
Reference
Core business
ONEGENE BIOTECHNOLOGY
Genuv
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
Genuv is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases by stimulating neural stem cells and restoring central nervous system (CNS) function. Their innovative approach includes targeting immune cells and utilizing phenotypic drug screening to discover substances that promote neuroprotection and neurogenesis.
Reference
Core business
Genuv
Biopharmaceutical company. 신약발굴 플랫폼 기술을 바탕으로 퇴행성 뇌질환, 면역질환, 암질환 등, 난치성 질환분야에서 치료제를 개발하는 연구 중심 신약 개발 기업.
PROTEINA
South Korea
A
- Employees
2015
Key takeaway
Proteina is focused on developing innovative diagnostic strategies that enhance the targeted treatment of cancer and other diseases, highlighting their expertise in protein interactions which could be relevant to peptide therapeutics. The company's commitment to precision medicine and strong intellectual property portfolio underscores its potential in transforming treatment approaches.
Reference
Core business
Proteina | Protein-Protein Interactions | About Us
Proteina creates novel technology that analyzes Protein-Protein-Interactions in new ways. Learn more about our company, our mission, and our technology.
Nexus Pharma co. ltd.
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
Nexus Pharma Co., Ltd. emphasizes its commitment to innovative solutions in the pharmaceutical and cosmeceutical sectors, highlighting its rigorous manufacturing and testing processes. This dedication to quality and efficacy may be relevant for those interested in peptide therapeutics.
Reference
Core business
About Us | Nexus Pharma
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
The company, Spidercore, focuses on enhancing gene therapy through its AI-driven platform that analyzes the properties of nucleotides to discover reliable gene therapies. Their innovative approach aims to improve clinical decision-making and patient outcomes in the promising field of gene-based medicine.
Reference
Core business
Spidercore Inc.
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
The company specializes in transforming cancer immunotherapy, cellular engineering, and genome editing through its innovative Hydroporator® platform, which enables highly effective delivery of therapeutic agents like plasmid DNA, mRNA, and proteins into primary cells. Their focus on microfluidic gene editing positions them at the forefront of peptide therapeutics and related therapies.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
Technologies which have been searched by others and may be interesting for you:
In the Peptide Therapeutics industry in South Korea, several key considerations are crucial for anyone conducting research. The regulatory environment is a vital aspect, as South Korea's Ministry of Food and Drug Safety (MFDS) oversees the approval and commercialization of peptide drugs, making compliance with stringent regulations essential. Understanding the local market dynamics is also important, as South Korea has a rapidly growing biotechnology sector, supported by significant government investment and research initiatives. Challenges include competition from established pharmaceutical companies and the need for continuous innovation to meet evolving healthcare demands. Opportunities abound due to South Korea’s strong emphasis on research and development, which fosters collaboration between academia and industry. Furthermore, the global relevance of peptide therapeutics is on the rise, with increasing applications in oncology and metabolic disorders, positioning South Korean companies to tap into international markets. Environmental concerns, while less pronounced than in other sectors, are gaining attention, particularly regarding the sustainability of manufacturing processes. Overall, a comprehensive understanding of these factors can significantly enhance strategic decision-making for those interested in the peptide therapeutics landscape in South Korea.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 16 |
| Amount of suitable service providers | 5 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2002 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Peptide Therapeutics?
Start-Ups who are working in Peptide Therapeutics are MxT Biotech
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Medical, Other, Pharmaceuticals, IT, Software and Services
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.